Blood Clot Concerns Prompt EU Restrictions For Pfizer's Xeljanz

 
• By Vibha Sharma
SideEffects
The EMA Is Re-Examining The Safety Of Xeljanz • Source: Shutterstock

More from Europe

More from Geography